Free Trial

DarioHealth Q3 2024 Earnings Report

DarioHealth logo
$0.63 -0.01 (-0.95%)
As of 09:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DarioHealth EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.18
Beat/Miss
Missed by -$0.07
One Year Ago EPS
-$0.49

DarioHealth Revenue Results

Actual Revenue
$7.42 million
Expected Revenue
$7.34 million
Beat/Miss
Beat by +$80.00 thousand
YoY Revenue Growth
N/A

DarioHealth Announcement Details

Quarter
Q3 2024
Time
Before Market Opens

Conference Call Resources

DarioHealth Earnings Headlines

Your chance to get on the next “60-Second Trade”
Even retirees are being forced back to work just to keep up. And if you're waiting for help from the Fed or government... Well, you might be waiting a very long time. But Roger Scott has uncovered something interesting... What if there was a way to fight back against inflation? A simple method you could use right from your phone...
See More DarioHealth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DarioHealth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DarioHealth and other key companies, straight to your email.

About DarioHealth

DarioHealth (NASDAQ:DRIO) operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

View DarioHealth Profile

More Earnings Resources from MarketBeat